Early Blood-based Liquid Biopsy in Patients with Treatment-na ïve Metastatic Adenocarcinoma of the Lung: A Case Series.
CONCLUSIONS: These findings suggest that cfDNA analysis should be ordered by the pulmonologists early in the evaluation of patients with NSCLC, which might complement the tumor biopsy.
PMID: 33381953 [PubMed - in process]
Source: The Israel Medical Association Journal - Category: General Medicine Tags: Isr Med Assoc J Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | General Medicine | Israel Health | Lung Cancer | Middle East Health | Non-Small Cell Lung Cancer | Smokers